title: Frequency of potentially inappropriate prescriptions in older people at discharge according to Beers and STOPP criteria.
abstract: BACKGROUND
  Potentially inappropriate prescriptions (PIP) are frequent, generate negative outcomes, and are to a great extent avoidable. Although there is general agreement about the definition of PIP, how to measure them is a matter of debate.
  
  
  OBJECTIVE
  Our aim was to measure the frequency of PIP in older people at hospital discharge using two sets of criteria--Beers (2012 update) and STOPP.
  
  
  METHODS
  A university hospital in southern Spain.
  
  
  METHODS
  This cross sectional study involved a random sample of patients 65 years or more discharged from the University Hospital San Cecilio (Granada, Spain), from July 1, 2011 to June 30, 2012. Age, gender, length of hospital stay, type of hospital service, drugs prescribed and pathologies were obtained from discharge reports.
  
  
  METHODS
  The main outcome measures were: (1) the prevalence of PIP according to each set of criteria (Beers and STOPP) and its 95 % confidence interval, globally and stratified for different categories of the study variables; (2) the degree of agreement between the two criteria using Kappa statistics; and (3) the drugs most commonly involved in PIP according to both criteria.
  
  
  RESULTS
  There were 624 patients (median age 78) included in our study. According to Beers criteria, 22.9 % (19.6-26.2 %) of the patients had at least one PIP. This figure was 38.4 % (34.6-42.2 %) for STOPP criteria. Just 13.6 % of the patients had prescriptions simultaneously inappropriate for both criteria. Higher PIP frequency was observed in patients discharged from internal medicine. PIP increased with the Charlson Index and with the number of drugs prescribed, but not with gender, age or length of hospital stay.
  
  
  CONCLUSIONS
  A very high frequency of PIP at discharge was observed. By intervening in five drug groups, about 80 % of PIP might be avoided according to either of the two criteria.
authors.affiliation: Department of Public Health and Preventive Medicine, Faculty of Medicine, University of Granada, Avenida de Madrid, 11, 18012, Granada, Spain.
authors.forename: Klejda
authors.initials: K
authors.lastname: Hudhra
authors.forename: Marta
authors.initials: M
authors.lastname: García-Caballos
authors.forename: Besnik
authors.initials: B
authors.lastname: Jucja
authors.forename: Eloisa
authors.initials: E
authors.lastname: Casado-Fernández
authors.forename: Elena
authors.initials: E
authors.lastname: Espigares-Rodriguez
authors.forename: Aurora
authors.initials: A
authors.lastname: Bueno-Cavanillas
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D003430:Cross-Sectional Studies; D005260:Female; D006785:Hospitals, University / Q000706:statistics & numerical data*; D006801:Humans; D057970:Inappropriate Prescribing / Q000706:statistics & numerical data*; D007902:Length of Stay; D008297:Male; D010351:Patient Discharge / Q000706:statistics & numerical data*; D019338:Polypharmacy
references.citation: Br J Clin Pharmacol. 2007 Feb;63(2):177-86
references.pmid: 17166186
references.citation: Farm Hosp. 2012 Jul-Aug;36(4):268-74
references.pmid: 22119167
references.citation: Int J Clin Pharm. 2013 Apr;35(2):230-5
references.pmid: 23225094
references.citation: Clin Interv Aging. 2010 Apr 07;5:75-87
references.pmid: 20396637
references.citation: Eur J Clin Pharmacol. 2012 Jul;68(7):1085-94
references.pmid: 22349159
references.citation: Am J Geriatr Pharmacother. 2010 Dec;8(6):562-70
references.pmid: 21356505
references.citation: Geriatr Gerontol Int. 2012 Jul;12(3):506-14
references.pmid: 22239067
references.citation: Br J Clin Pharmacol. 2009 Dec;68(6):936-47
references.pmid: 20002089
references.citation: Int J Clin Pharmacol Ther. 2008 Feb;46(2):72-83
references.pmid: 18218287
references.citation: Int J Clin Pharmacol Ther. 2012 Mar;50(3):185-94
references.pmid: 22373831
references.citation: BMC Cancer. 2004 Dec 20;4:94
references.pmid: 15610554
references.citation: Eur J Clin Pharmacol. 2011 Nov;67(11):1175-88
references.pmid: 21584788
references.citation: Age Ageing. 2008 Nov;37(6):673-9
references.pmid: 18829684
references.citation: Age Ageing. 2013 Jan;42(1):116-20
references.pmid: 22832380
references.citation: Expert Rev Clin Pharmacol. 2012 Mar;5(2):187-97
references.pmid: 22390561
references.citation: Eur J Clin Pharmacol. 2012 Oct;68(10):1425-33
references.pmid: 22447297
references.citation: Lancet. 2007 Jul 14;370(9582):173-184
references.pmid: 17630041
references.citation: Mt Sinai J Med. 2011 Jul-Aug;78(4):613-26
references.pmid: 21748749
references.citation: BMC Geriatr. 2011 Nov 30;11:79
references.pmid: 22129458
references.citation: Ann Intern Med. 2001 Oct 16;135(8 Pt 2):642-6
references.pmid: 11601946
references.citation: J Am Geriatr Soc. 2012 Apr;60(4):616-31
references.pmid: 22376048
references.citation: Outcomes Manag. 2002 Oct-Dec;6(4):182-5
references.pmid: 12385170
references.citation: Am J Geriatr Pharmacother. 2012 Oct;10(5):284-95
references.pmid: 22944511
references.citation: Rev Esp Geriatr Gerontol. 2009 Sep-Oct;44(5):273-9
references.pmid: 19540624
references.citation: Drugs Aging. 2012 Oct;29(10):829-37
references.pmid: 23044639
references.citation: An Med Interna. 2008 Jun;25(6):269-74
references.pmid: 19295973
references.citation: Drugs Aging. 2009 Dec;26 Suppl 1:31-9
references.pmid: 20136167
references.citation: Pharmacotherapy. 2012 Nov;32(11):e338-47
references.pmid: 23108762